BioLine Rx Ltd (BLRX)
0.613
-0.02
(-3.74%)
USD |
NASDAQ |
Apr 24, 16:00
0.6101
0.00 (0.00%)
After-Hours: 20:00
BioLine Rx Free Cash Flow: -22.90M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -22.90M |
| September 30, 2023 | -33.79M |
| June 30, 2023 | -32.57M |
| March 31, 2023 | -29.10M |
| December 31, 2022 | -26.56M |
| September 30, 2022 | -26.21M |
| June 30, 2022 | -22.51M |
| March 31, 2022 | -23.03M |
| December 31, 2021 | -23.67M |
| September 30, 2021 | -23.54M |
| June 30, 2021 | -24.00M |
| March 31, 2021 | -22.72M |
| December 31, 2020 | -23.21M |
| September 30, 2020 | -23.22M |
| June 30, 2020 | -23.92M |
| March 31, 2020 | -24.82M |
| December 31, 2019 | -22.74M |
| September 30, 2019 | -32.53M |
| June 30, 2019 | -32.38M |
| March 31, 2019 | -32.17M |
| December 31, 2018 | -34.41M |
| September 30, 2018 | -25.90M |
| June 30, 2018 | -26.12M |
| March 31, 2018 | -24.12M |
| December 31, 2017 | -24.78M |
| Date | Value |
|---|---|
| September 30, 2017 | -22.00M |
| June 30, 2017 | -18.75M |
| March 31, 2017 | -17.79M |
| December 31, 2016 | -14.57M |
| September 30, 2016 | -14.04M |
| June 30, 2016 | -15.78M |
| March 31, 2016 | -17.60M |
| December 31, 2015 | -16.89M |
| September 30, 2015 | -18.28M |
| June 30, 2015 | -16.86M |
| March 31, 2015 | -16.12M |
| December 31, 2014 | -15.94M |
| September 30, 2014 | -15.03M |
| June 30, 2014 | -16.02M |
| March 31, 2014 | -17.81M |
| December 31, 2013 | -19.64M |
| September 30, 2013 | -22.55M |
| June 30, 2013 | -22.31M |
| March 31, 2013 | -21.98M |
| December 31, 2012 | -20.29M |
| September 30, 2012 | -17.59M |
| June 30, 2012 | -14.53M |
| March 31, 2012 | -12.60M |
| December 31, 2011 | -11.51M |
| September 30, 2011 | -9.557M |
Free Cash Flow Range, Past 5 Years
-33.79M
Minimum
Sep 2023
-22.51M
Maximum
Jun 2022
-25.97M
Average
-23.92M
Median
Jun 2020
Free Cash Flow Benchmarks
| Compugen Ltd | -- |
| Pluri Inc | -18.82M |
| XTL Biopharmaceuticals Ltd | -- |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | -21.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.991M |
| Cash from Investing (Quarterly) | -20.40M |
| Cash from Financing (Quarterly) | 11.74M |
| Free Cash Flow Per Share (Quarterly) | 0.0692 |
| Free Cash Flow to Equity (Quarterly) | 6.736M |
| Free Cash Flow Yield | -58.18% |